Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    U.S. Hotel Construction Shrinks Again for Ninth Consecutive Month

    October 23, 2025

    AWS Restores Services After Major Cloud Outage Disrupts Users Globally

    October 22, 2025

    Palantir, Snowflake’s Big AI Data Partnership Fails to Win Over Investors

    October 17, 2025
    Facebook X (Twitter) Instagram LinkedIn
    • About Us
    • Press Release
    Friday, October 24
    Facebook X (Twitter) LinkedIn Instagram
    Business Leaders Review: Best Business Magazine and News OnlineBusiness Leaders Review: Best Business Magazine and News Online
    • Home
    • Magazines
    • Featured Leaders
    • Technology
      • Big Data
      • Artificial Intelligence
      • Robotics
      • Cloud
      • Cyber Security
      • Storage
      • IoT
      • Blockchain
      • Data Analytics
    • Industry
      • Banking & Finance
      • Construction
      • Digital Marketing
      • Economy
      • Education
      • EV Industry
      • Food & Beverage
      • Healthcare
      • Legal
      • Manufacturing
      • Mining & Metals
      • Pharmaceutical
    • Testimonials
    • Events
    • Blogs
    • Awards
    • Our Clients
    Business Leaders Review: Best Business Magazine and News OnlineBusiness Leaders Review: Best Business Magazine and News Online
    Home » Mifepristone, which is the first of two drugs used to terminate a pregnancy, will be available in local drug stores in states where abortion is permitted.
    Healthcare

    Mifepristone, which is the first of two drugs used to terminate a pregnancy, will be available in local drug stores in states where abortion is permitted.

    By Business Leaders ReviewJanuary 4, 2023

    Retail pharmacies in the United States will be permitted to sell abortion pills, health officials said Tuesday, a move that could significantly expand access to the procedure after last year’s landmark Supreme Court ruling that overturned federal abortion rights.

    Regulatory changes announced by the Food and Drug Administration mean that mifepristone, which is the first of two drugs used to terminate a pregnancy, will be available in local drug stores in states where abortion is permitted.

    A doctor’s prescription will be needed to obtain the pills, which were previously only available from a few mail-order pharmacies or certified doctors and clinics.

    Demand for abortion pills has risen since the conservative-dominated Supreme Court made a landmark ruling last June that overturned Roe v. Wade, a 1973 case that had guaranteed women’s right to an abortion for half a century.

    Abortion pills are already used in more than half of US procedures to terminate a pregnancy, experts say, and they have increasingly become a focus in the political and legal battle for abortion rights since the Supreme Court’s controversial decision.

    Pharmacies will need to receive certification to dispense the drug, while patients will need to complete a consent form.

    The FDA’s decision was welcomed by the American Civil Liberties Union.

    “We are happy the FDA has increased pharmacy access to this safe and effective medication, relieving one of the agency’s needless burdens on mifepristone patients,” said Julia Kaye of the ACLU’s Reproductive Freedom Project.

    Marjorie Dannenfelser, president of the anti-abortion organization Susan B. Anthony List slammed the decision.

    “The Biden administration has once again proved that it values abortion industry profits over women’s safety and unborn children’s lives,” Dannenfelser said in a statement.

    Related Posts

    U.S. Hotel Construction Shrinks Again for Ninth Consecutive Month

    October 23, 2025

    AWS Restores Services After Major Cloud Outage Disrupts Users Globally

    October 22, 2025

    Palantir, Snowflake’s Big AI Data Partnership Fails to Win Over Investors

    October 17, 2025

    China Blamed for Major Breach at U.S. Cybersecurity Giant F5, Reports Bloomberg

    October 17, 2025

    Pfizer CEO Urges US Pharma Industry to Partner with China

    October 16, 2025

    Stadler Boosts Production Speed with Panasonic’s Automated Robot Welding System

    October 15, 2025
    Top Posts

    U.S. Hotel Construction Shrinks Again for Ninth Consecutive Month

    October 23, 2025

    AWS Restores Services After Major Cloud Outage Disrupts Users Globally

    October 22, 2025

    Palantir, Snowflake’s Big AI Data Partnership Fails to Win Over Investors

    October 17, 2025
    Don't Miss

    U.S. Hotel Construction Shrinks Again for Ninth Consecutive Month

    October 23, 2025

    Key Highlights The U.S. hotel construction pipeline contracted for the ninth consecutive month, underscoring the…

    AWS Restores Services After Major Cloud Outage Disrupts Users Globally

    October 22, 2025

    Palantir, Snowflake’s Big AI Data Partnership Fails to Win Over Investors

    October 17, 2025

    China Blamed for Major Breach at U.S. Cybersecurity Giant F5, Reports Bloomberg

    October 17, 2025
    Stay In Touch
    • Facebook
    • Twitter
    • Instagram
    • LinkedIn
    About Us
    About Us

    Business Leaders Review is a global print and digital monthly and yearly magazine, which provides a platform to showcase business/tech leaders and their company’s profile from various sectors. Our aim is to publish the c-suite leaders stories.

    We are helping the leaders & readers to showcase their ideas and innovations to the business and tech world in this current market situation along with their awards and achievements. Doing so we hope to leverage thousands of businesses and personnel around the globe.

    Most Popular

    U.S. Hotel Construction Shrinks Again for Ninth Consecutive Month

    AWS Restores Services After Major Cloud Outage Disrupts Users Globally

    Palantir, Snowflake’s Big AI Data Partnership Fails to Win Over Investors

    Latest Magazines
    Facebook X (Twitter) LinkedIn Instagram
    • Home
    • Our Clients
    • TECHNLOGY NEWS
    • Industry News
    • Contact Us
    • Privacy Policy
    • Reprints and Permissions
    © 2021-2025 Business Leaders Review LLC | All Rights Reserved | Empowering Communication Globally

    Type above and press Enter to search. Press Esc to cancel.